Bunkerhill Health, a specialist in healthcare AI infrastructure, has successfully concluded its Series B financing, securing $55 million in total capital raised. This latest round was spearheaded by Khosla Ventures.

The company's flagship product, Carebricks, enables healthcare organizations to develop and implement their proprietary AI agents. These agents can be utilized across clinical, operational, and administrative functions, eliminating the need for disparate, vendor-created solutions.

The Carebricks platform, which is already in use at the University of Texas Medical Branch (UTMB) and operates at an institutional level, features FDA-approved algorithms. These have been instrumental in enabling critical, life-saving actions, such as the deployment of a coronary calcium agent that led to an immediate triple bypass surgery.

Carebricks offers health systems a unified base for creating and deploying customized AI agents across various departments, including clinical, operational, and administrative areas. Prominent academic and regional health systems, such as Cleveland Clinic, Intermountain Health, and the University of Texas Medical Branch (UTMB), are currently utilizing the platform.